These findings are consistent with those of previous reports showing PD‐L1 overexpression in various malignancies, including lung[29, 30, 31] and breast cancers,[32, 33, 34] where it was correlated with immune evasion and poor prognosis. This evidence concerns the gene CD274 and breast carcinoma.